Form 4: Senseonics Holdings Director, Anthony R. Raab, Receives Stock Grant

Sentiment:

SEC Form 4


Director Anthony R. Raab acquired 236,344 shares of Senseonics Holdings common stock through a restricted stock unit (RSU) grant.

Summary

  • On May 22, 2024, Anthony R. Raab, a director of Senseonics Holdings, Inc., acquired 236,344 shares of common stock.
  • The acquisition was in the form of a restricted stock unit (RSU) grant.
  • The RSUs vest in full on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting, contingent upon continuous service.
  • Each RSU represents the right to receive one share of Senseonics Holdings common stock.
  • Following the transaction, Raab directly owns 700,871 shares of Senseonics Holdings common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

  • The RSU grant aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The vesting of the RSUs is contingent upon continued service, suggesting an expectation of Raab's ongoing involvement with Senseonics Holdings.

Industry Context

Stock grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

  • Stock grants to directors are a standard practice across the medical device industry, similar to companies like Dexcom and Abbott, who also use equity-based compensation to align director and executive incentives with shareholder value.
  • The vesting schedule of one year or the next annual meeting is also typical, mirroring practices seen in comparable companies.

Stakeholder Impact

  • The RSU grant aligns the director's interests with those of shareholders, potentially leading to decisions that benefit shareholder value.

Key Dates

DateDescription
05/22/2024Date of the RSU grant to Anthony R. Raab.
05/24/2024Date of signature by Attorney-in-Fact, Darren K. DeStefano.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.